MTND4P24: A Drug Target / Disease Biomarker (G100873254)

Target Name: MTND4P24

NCBI ID: G100873254

MTND4P24

Other Name(s): MT-ND4 pseudogene 24

MTND4P24: A Drug Target / Disease Biomarker

MTND4P24 is a drug target (or biomarker) that is being studied for its potential therapeutic effects in the treatment of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions.

MTND4P24 is a protein that is expressed in the brain and has been shown to play a role in the development and progression of these disorders. It is a potential drug target because it is involved in the formation of beta-amyloid plaques, a hallmark of Alzheimer's disease, and has been shown to interact with other proteins that are also involved in the development of these disorders.

One of the main reasons for the potential therapeutic effects of MTND4P24 is its ability to cross the blood-brain barrier and interact with the brain. This is important because many drugs that are used to treat these disorders have limited success because they cannot reach the brain. By using MTND4P24 as a drug target, researchers hope to be able to develop drugs that can specifically target this protein and help to treat the underlying neurological disorders.

In addition to its potential therapeutic uses, MTND4P24 is also being studied for its potential diagnostic uses. By using it as a biomarker, researchers can test for the presence of this protein in the brain and use this information to diagnose the onset of these disorders. This could have the potential to revolutionize the field of neurology by allowing for earlier and more accurate diagnoses.

Another promising aspect of MTND4P24 is its potential to be used in combination with other treatments. Because it is involved in the formation of beta-amyloid plaques, researchers are exploring the possibility of using MTND4P24 as a drug target in combination with drugs that can specifically target this protein. This could help to increase the effectiveness of these treatments and potentially reduce the risk of side effects.

Overall, MTND4P24 is a drug target (or biomarker) that has the potential to revolutionize the field of neurology. By using it as a therapeutic or diagnostic tool, researchers hope to be able to develop new treatments for a variety of neurological disorders.

Protein Name: MT-ND4 Pseudogene 24

The "MTND4P24 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTND4P24 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets